ISSN: 1473-3099

Journal Home

Journal Guideline

The Lancet Infectious Diseases Q1 Unclaimed

Lancet Publishing Group United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

The Lancet Infectious Diseases is a journal indexed in SJR in Infectious Diseases with an H index of 217. It has an SJR impact factor of 9,04 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Infectious Diseases (Q1)

Price

- €

Gold OA

-

Green OA

- €

Non OA

Metrics

9,04

SJR Impact factor

217

H Index

517

Total Docs (Last Year)

1457

Total Docs (3 years)

9231

Total Refs

10386

Total Cites (3 years)

479

Citable Docs (3 years)

20,21

Cites/Doc (2 years)

17,85

Ref/Doc

Aims and Scope

Other journals with similar parameters

Clinical Microbiology Reviews Q1
Microbiology and Molecular Biology Reviews Q1
The Lancet HIV Q1
FEMS Microbiology Reviews Q1
Current Opinion in Microbiology Q1

Best articles

2017 ECIL 7 vaccine guidelines

A European CDC

Acute lung injury and other serious complications of Plasmodium vivax malaria

African tick bite fever

All for one and one for all: the true potential of whole-genome sequencing

Amoebae hide a giant

Antimicrobial therapy to prevent or treat oral mucositis

Avascular necrosis of femoral heads in a man with HIV infection

Challenges and opportunities for the management of infectious diseases in Europes' prisons: evidence-based guidance

Challenges in tracking global malaria spending

Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso

Clinton pledges cheap antiretrovirals

SHOW MORE ARTICLES

Consumers need to change attitude to antibiotic use

Controversial antibiotic use for crops approved in Florida

Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens

De Libris

Development and evaluation of influenza pandemic vaccines

Development of vaccines against influenza H5

Early prevention of pertussis is key

Early prevention of pertussis is key -Author's reply

Efficacy and effectiveness of ten-valent versus 13-valent pneumococcal conjugate vaccines

Efficacy and effectiveness of ten-valent versus 13-valent pneumococcal conjugate vaccines -Authors' reply

Emergency diagnosis and treatment of adult meningitis

Epstein-Barr virus further linked to Hodgkin's lymphoma

Comments

No comments ... Be the first to comment!

Publication speed

Review quality

Edition and editorial team

Paper Link

Attach one of your papers. We need to confirm that you have had a relation with this journal in order to review its service.